Worldwide: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

FDA Gives Rise To A New Era In Sunscreen Regulation (Podcast)

Wiley's Environmental and FDA Regulatory practices launch a new joint podcast examining the intersection of environmental policy, scientific innovation, and FDA-regulated industries.

United States Healthcare

WR

Wiley Rein

Your PBM Has Some Explaining To Do: What The 2026 CAA Forces PBMs To Reveal

The Consolidated Appropriations Act of 2026 introduces sweeping changes to pharmacy benefit manager oversight, mandating comprehensive disclosure requirements and rebate pass-through obligations that will fundamentally...

United States Employment

JB

Jenner & Block

President Trump Imposes Section 232 Tariffs On Pharmaceuticals: What Importers Need To Know

President Trump's April 2026 proclamation imposes tariffs up to 100% on patented pharmaceutical products under Section 232, citing national security concerns over US reliance on foreign drug sources.

United States International

SR

McDermott Will & Schulte

FDA Sends Notices To More Than 2,200 Sponsors Regarding Unpublished Clinical Trial Results

The FDA has sent reminder letters to over 2,200 drug, biologic, and medical device companies regarding potential failures to publish required clinical trial results on ClinicalTrials.gov.

United States Healthcare

GT

Greenberg Traurig, LLP

A Billion-Dollar Trade On The Brink: How To Save The Hemp Beverage Industry

United States Cannabis

CH

Clark Hill

FDA Clarifies Policies For Pharmacy Compounders Of GLP-1 Products

United States Healthcare

FL

Foley & Lardner

CMS Bets On The Long Game With 10‑Year LEAD ACO Model

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Ready For 2027? CMS Issues Contract Year 2027 Final Rule And Announcement Of Rates And Payment Policies For Medicare Advantage And Medicare Part D

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA’s Human Foods Program Research Needs Include Assessing Nanoparticles

United States Healthcare

BC

Bergeson & Campbell

Sixth Circuit Holds ERISA Preempts Tennessee’s Pharmacy Anti-Steering Laws

United States Healthcare

M

Mintz

The Document Few May Read And Why It Is The Most Important Thing In Your SNP

United States Healthcare

AC

Ankura Consulting Group LLC

CMS Finalizes Rate Notice For Medicare Parts C And D (CY 2027)

United States Healthcare

CM

Crowell & Moring LLP

From Guidance To The Galley: CMS Urges DGA‑Aligned Menus And Procurement Under Hospital CoPs

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Recent Federal Developments For April 2026

United States Environment

BC

Bergeson & Campbell

What Every Multinational Should Know About…Managing The Aftermath Of The Supreme Court's IEEPA Tariff Decision (Part I)

United States International

FL

Foley & Lardner

Littler Lounge: Just Cause For A Chat About Corrective Actions (Podcast)

United States Employment

LM

Littler Mendelson

Gabriel Pinilla On Coffee Shops: La Voz De Los Ruferos (Podcast)

United States Real Estate

Aa

Adams and Reese

401(k) And IRA Contribution Limits For 2026: Retirement Savings, Adjustments For Inflation, And SECURE 2.0 Changes American Taxpayers Must Know About

United States Tax

RS

Rotfleisch & Samulovitch P.C.

Federal Circuit: Priority Document That 'Broadly Outlines' Possible Structures Fails To Provide Adequate Written Description Support For Subgenus Of Linkers In Antibody-Drug Conjugate

United States IP

AG

Akin Gump Strauss Hauer & Feld LLP

From Guidance To The Galley: CMS Urges DGA‑Aligned Menus And Procurement Under Hospital CoPs

On March 30, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a Quality & Safety Special Alert Memo (QSSAM) to hospitals and Critical Access Hospital (CAH) providers titled...

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

New Advertising Code For Food Products

As of 1 February 2026, stricter rules apply to advertising food products aimed at children and young people. The revised Advertising Code for Food Products (RVV 2026) has now entered into force.

United States Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

A Hard Pill To Swallow: 100% Tariffs Hit Pharma

While Section 232 tariffs have so far been largely a metals-and-autos story, pharma has now officially joined the narrative.

United States Healthcare

AF

ArentFox Schiff

States Continue To Advance New PBM And Drug Pricing Legislation In 2026

While federal and state legislators contemplate the next wave of PBM and drug pricing reform, legislatures in Virginia and Ohio have already sent significant legislation addressing...

United States Healthcare

M

Mintz

FDA Approves Extended Dosing Interval For Regeneron’s EYLEA HD (Aflibercept)

United States Healthcare

GP

Goodwin Procter LLP

Teva Receives FDA Approval Of Denosumab Biosimilar And Filing Acceptances By FDA And EMA For Omalizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

EPA Proposes Sixth SDWA Contaminant Candidate List, Kicking Off Potentially Significant Consequences For Multiple Industries

United States Environment

BD

Beveridge & Diamond

FDA Turns Up The Heat On GLP 1 Dupes Sold "For Research Use Only," Finds Intended Use Suggests Otherwise

United States Media & IT

KD

Kelley Drye & Warren LLP

ERISA Preemption – Alive And Well

United States Employment

BB

Bass, Berry & Sims

FTC Mandates Point-of-Sale Rebates For Prescription Drugs

United States Healthcare

HB

Hall Benefits Law

Cosmetics Under The Microscope: FDA’s Expanding Regulatory Reach Under MoCRA

United States Healthcare

CM

Crowell & Moring LLP

Massachusetts Court Narrows One Chip Challenge Lawsuit At Motion To Dismiss Stage

United States Consumer

GT

Greenberg Traurig, LLP

Federal And State Policymakers Push Forward With PBM And Drug Pricing Reform Even In The Wake Of Sweeping Actions Earlier This Year

United States Healthcare

M

Mintz

Nursing Home Fraud One Of Many Targets Of DOJ Enforcement Division

United States Healthcare

RB

Reinhart Boerner Van Deuren s.c.

Nursing Home Fraud One Of Many Targets Of DOJ Enforcement Division

The U.S. Department of Justice (DOJ) recently conveyed a desire to enhance fraud enforcement across multiple government programs...

United States Healthcare

RB

Reinhart Boerner Van Deuren s.c.

Massachusetts Court Narrows One Chip Challenge Lawsuit At Motion To Dismiss Stage

On March 31, 2026, the United States District Court for the District of Massachusetts granted in part and denied in part defendants' motions to dismiss in Lama-Wolobah v. Paqui, LLC...

United States Consumer

GT

Greenberg Traurig, LLP

A Tough Dose: 100% Tariffs Target Foreign-Manufactured Brand-Name Pharmaceuticals

The Trump administration has moved to impose a 100% tariff on imports of brand-name, patented pharmaceutical products and ingredients, while extending lower rates for jurisdictions that have entered into bilateral agreements with the United States...

United States Healthcare

JD

Jones Day

Cosmetics Under The Microscope: FDA’s Expanding Regulatory Reach Under MoCRA

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years...

United States Healthcare

CM

Crowell & Moring LLP

FDA Dives Deeper Into The Use Of Digital Health Technologies In Drug Development With New RFI

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

What To Watch: FDA's FY 2027 Budget

FDA released its FY 2027 congressional justification last week. The $7.2 billion topline is less interesting than what's underneath it—the budget translates this administration's policy signals into concrete funding and legislative asks...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Podcast - Why Recall Planning Matters For Every Food Company

A food recall can escalate from a routine operational issue to a full-scale business crisis in a matter of hours, which is why preparation is mandatory for food companies of any size.

United States Healthcare

HK

Holland & Knight

Trade Winds Shift For Pharma: Understanding The Section 232 Tariff Proclamation On Pharmaceuticals

On April 2, 2026, President Trump signed a proclamation implementing tariffs on certain pharmaceutical products pursuant to Section 232 of the Trade Expansion Act of 1962 (19 U.S.C. § 1862).

United States International

AP

Arnold & Porter

The Learned Concierge - April 2026, Vol. 29

Welcome to your monthly legal insights on the trends impacting the Retail, Hospitality, and Food & Beverage Industries.

United States Healthcare

CH

Clark Hill

A Recipe For Exclusion: Why The Baby Food MDL Experts Failed Under Daubert

United States Healthcare

WS

Winston & Strawn LLP

CBD, Medicare, And The New FDA Enforcement Memo

United States Cannabis

HS

Harris Sliwoski

The Fall Of Done Global: When Telehealth Becomes A Pipeline For Controlled Substances

United States Healthcare

SH

Sanford Heisler Sharp McKnight

Telehealth Prescription Fraud: What Whistleblowers Should Know About Reporting It

United States Criminal

SH

Sanford Heisler Sharp McKnight

FDA Presses Forward On Incorporating Patient Preferences In Device Decision Making, Releases Updated Final Guidance

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Mandatory Credential Denials Create New Compliance Challenges For Maritime Employers

United States Transport

JW

Jones Walker

2026 Perspectives In Private Equity: Food & Agriculture

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Healthcare Private Equity Outlook: Takeaways From HPE Miami 2026

United States Healthcare

SR

McDermott Will & Schulte

PFAS In The EU: A Regulatory Turning Point

European Union Environment

AO

A&O Shearman

AI Hallucinations In Court: A Case Study In How Bad It Can Get

United States Technology

D

Dechert

UPDATE: 21 State Attorneys General Sue To Block USDA Standardized Grant Conditions

United States Healthcare

WR

Wiley Rein

High Court's 'Skinny Label' Case May Tackle Wider Questions

United States Healthcare

TS

Taft Stettinius & Hollister

CVS Caremark Settles FTC Insulin Pricing Lawsuit: Key Developments And Industry Impact

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

S.D. Governor Signs Lab-Grown Meat Moratorium

United States Healthcare

SH

Shook, Hardy & Bacon

Cash Is Back: New York Requires Retailers And Food Establishments To Accept Cash Payments

United States Healthcare

BS

Bond, Schoeneck & King PLLC

See more

Highlighted Content

The Nexus Of Trade And Food Security Amid Global Conflicts

United States International

BG

Braumiller Law Group, PLLC

Any Comments On FDA's New Proposed Rule On Prior Notice Regulations?

United States International

BG

Braumiller Law Group, PLLC

World Trade And Invasion, One Year Later – Are We On The Brink Of A New World Order?

United States International

BG

Braumiller Law Group, PLLC

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

Latest Videos

See more

A Flurry Of Changes For Plan Sponsors, Prescription Drug Plans And Health Plan Vendors (Video)

RB

Reinhart Boerner Van Deuren s.c.

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

The Exploration Crisis: Why Oil & Gas Companies Are Finding Less While Demand Keeps Growing (Video)

AM

Alvarez & Marsal

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More